Eli Lilly strikes a $3 billion Chinese drug deal

In April, President Trump signed an executive order slapping 100% tariffs on patented pharmaceutical imports. The idea: force drugmakers to bring manufacturing back to American soil — an America First bet that U.S. medicine should be made in the U.S.

Two months later, one of the country's biggest pharmaceut